Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia
Ghia, P, Coutre, S.E, Furman, R.R, Sharman, J.P, Cheson, B.D, Pagel, J.M, Hillmen, P, Barrientos, J.C, Zelenetz, A.D, Kipps, T.J, Flinn, I.W, Eradat, H.A, Lamanna, N, Coiffier, B, Pettitt, A, Li, X, Jahn, T.M, O'Brien, S.M, Hallek, M.J
Published in Journal of geriatric oncology (01.10.2014)
Published in Journal of geriatric oncology (01.10.2014)
Get full text
Journal Article
659P Combination treatment with TTX-030, a first-in-class anti-CD39 antibody, in patients with advanced pancreatic cancer
Wainberg, Z.A., Cha, Y., George, B., Grewal, J.S., Merchan, J.R., Mckean, M., Soares, H.P., Cruz, T.D., Moesta, A.K., Jahn, T.M., Singhal, A.K., Tribouley, C., Kongpachith, S., Afar, D.E., Mitra, S., Spigel, D.R., Balaraman, R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article